CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
1639014-61-2 | 4-氯苯乙基碘化胺 | 4-Chlorophenylethylammonium Iodide | C8H11ClIN | 283.54 | | |
1639024-15-9 | Karavilagenin F | | C31H50O5 | 502.73 | | 616.6±55.0 °C(Predicted) |
1639042-08-2 | | azd9496 | C25H25F3N2O2 | 442.47 | | |
1639042-28-6 | | azd9496 maleate | C29H29F3N2O6 | 558.55 | | |
1639042-39-9 | (e)-3-(3,5-二氟-4-甲酰基苯基)丙烯酸甲酯 | methyl (e)-3-(3,5-difluoro-4-formylphenyl)acrylate | C11H8F2O3 | 226.18 | | 320.9±42.0°C at 760 mmHg |
1639050-53-5 | (e)-2-(2,4-二氧代噻唑烷-5-亚基)乙酸 | (e)-2-(2,4-dioxothiazolidin-5-ylidene)acetic acid | | | | |
16391-06-3 | | Methyl-phosphinic acid methyl ester | C2H7O2P | 94.05 | | |
16391-75-6 | | bis(2-hydroxyethyl)ammonium fusidate | | | | |
1639111-11-7 | 8-甲基-3,8-二氮杂双环[3.2.1]辛烷-3-羧酸叔丁酯 | tert-Butyl 8-methyl-3,8-diazabicyclo[3.2.1]octane-3-carboxylate | C12H22N2O2 | 226.32 | | |
1639112-63-2 | {4,6-二甲基-1h-吡咯并[2,3-b]吡啶-5-基}甲胺 | {4,6-dimethyl-1h-pyrrolo[2,3-b]pyridin-5-yl}methanamine | | | | |
1639113-91-9 | [3-(methoxymethyl)oxetan-3-yl]methanol | | C6H12O3 | 132.159 | | |
1639114-94-5 | ethyl 1-cyclopropyl-1H-pyrazole-5-carboxylate | | C9H12N2O2 | 180.207 | | |
1639115-07-3 | ethyl 1-cyclopropyl-1H-pyrazole-3-carboxylate | | C9H12N2O2 | 180.207 | | |
1639115-99-3 | 3,8-二甲基-6-硝基-[1,2,4]三唑并[4,3-a]吡啶 | 3,8-dimethyl-6-nitro-[1,2,4]triazolo[4,3-a]pyridine | C8H8N4O2 | 192.178 | | |
1639116-32-7 | | 6-bromo-1,4-dimethyl-1h-benzo[d][1,2,3]triazole | C8H8BrN3 | 226.07 | | |
1639116-68-9 | | 5-chloro-3,7-dimethyl-3h-[1,2,3]triazolo[4,5-b]pyridine | | | | |
1639116-75-8 | (6-氯-3-甲基-[1,2,4]三唑并[4,3-b]哒嗪-8-基)氨基甲酸叔丁酯 | tert-Butyl (6-chloro-3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-8-yl)carbamate | C11H14ClN5O2 | 283.71 | | |
163912-46-7 | | hexanedioic acid, polymer with 1,3-diisocyanatomethylbenzene, 2,5-furandione an | | | | |
163912-47-8 | | 1,4-benzenedicarboxylic acid, polymer with 2,2-dimethyl-1,3-propanediol, 2,5-fu | | | | |
163913-87-9 | 髓鞘少突胶质细胞糖蛋白肽片段35-55 | myelin oligodendrocyte glycoprotein peptide fragment 35-55 rat, mouse | C118H177N35O29S | | | |
1639134-02-3 | 2,3,6,7-四(4-甲酰基苯基)四硫富瓦烯 | 4,4',4'',4'''-([2,2'-Bi(1,3-dithiolylidene)]-4,4',5,5'-tetrayl)tetrabenzaldehyde | C34H20O4S4 | 620.78 | | |
1639137-80-6 | (E)-2-((1-乙酰基-3-(2-(吡啶-2-基)乙烯基)-1H-吲唑-6-基)硫代)-N-甲基苯甲酰胺(阿西替尼杂质) | (E)-2-((1-Acetyl-3-(2-(Pyridin-2-Yl)Vinyl)-1H-Indazol-6-Yl)Thio)-N-Methylbenzamide | C24H20N4O2S | 428.51 | | |
1639138-00-3 | 2-((1-乙酰基-3-碘-1H-吲唑-6-基)硫基)-N-甲基苯甲酰胺(阿西替尼杂质) | 2-((1-Acetyl-3-iodo-1H-indazol-6-yl)thio)-N-methylbenzamide(AxitinibImpurity) | C17H14IN3O2S | 451.28 | | |
1639198-67-6 | | na-azido-nd-boc-l-ornithine cyclohexylammonium salt | | | | |
1639205-66-5 | | mpeg11-ch2cooh | | | | |
1639205-98-3 | 2-(7-氟-3,4-二氢-3-氧代-4-(丙-2-炔基)-2h-苯并[b][1,4]恶嗪-6-基)-3a,4,7,7a-四氢-2h-异吲哚-1,3-二酮 | 2-(7-fluoro-3,4-dihydro-3-oxo-4-(prop-2-ynyl)-2h-benzo[b][1,4]oxazin-6-yl)-3a,4,7,7a-tetrahydro-2h-isoindole-1,3-dione | | | | |
1639207-37-6 | Rac-1-oleoyl-2-chloropropanediol | | C21H39ClO3 | 374.992 | | |
1639207-42-3 | (Z)-2-Chloropropane-1,3-diyl Dioleate | | C39H71ClO4 | 639.443 | | |
1639208-54-0 | Valbenazine tosylate | NBI-98854 | C38H54N2O10S2 | 762.97 | | |
163921-61-7 | 氟康唑杂质10 | fluconazole impurity 10 | | | | |
163921-62-8 | 氟康唑杂质8 | fluconazole impurity 8 | | | | |
163921-65-1 | 阿奇霉素-d3 | azithromycin-d3 | C38H69D3N2O12 | 752 | 125-129°C | |
1639210-89-1 | 5-溴-3,4-二甲基噻吩并[2,3-c]哒嗪-6-甲腈 | 5-bromo-3,4-dimethylthieno[2,3-c]pyridazine-6-carbonitrile | | | | |
1639220-15-7 | Sigma-1 receptor antagonist 2 | | C20H26ClN3O2 | 375.89 | | |
1639220-17-9 | Sigma-1 receptor antagonist 3 | | C19H23ClFN3O | 363.86 | | |
1639220-19-1 | Sigma-1 receptor antagonist 1 | | C19H23Cl2N3O | 380.31 | | |
1639263-80-1 | 沃替西汀杂质27 | vortioxetine impurity 27 | | | | |
163927-29-5 | | (R)-(-)-4-(3-Isothiocyanato-pyrrolidino)-7-nitro-benzofurazan | C11H9N5O3S | 291.28 | | |
163927-30-8 | | (S)-(+)-4-(3-Isothiocyanato-pyrrolidino)-7-nitro-benzofurazan | C11H9N5O3S | 291.28 | | |
163927-31-9 | | (R)-(-)-1-[7-(Dimethylaminosulfonyl)benzofurazan-4-yl]pyrrolidin-3-yl isothiocyanate | C13H15N5O3S2 | 353.41 | 157-160℃ | |
163927-32-0 | | dimethylaminosulfonylisothiocyanatop | C13H15N5O3S2 | 353.41 | 157-160℃ | |
1639289-05-6 | 2-溴-1-甲基-1H-咪唑-4-羧酸乙酯 | Ethyl 2-bromo-1-methyl-1H-imidazole-4-carboxylate | C7H9BrN2O2 | 233.06 | | |
1639298-89-7 | 4-氯-2-氟-5-硝基苯甲醛 | 4-Chloro-2-fluoro-5-nitrobenzaldehyde | | | | |
163930-30-1 | 1-((4-(2-碘乙基)苯氧基)甲基)苯 | 1-((4-(2-iodoethyl)phenoxy)methyl)benzene | C15H15IO | 338.18 | | 398.0±30.0 °C(Predicted) |
163931-61-1 | | tetrabutylammonium triphenyldifluorosilicate (tbat) | C34H51F2NSi | 539.86 | 147-148℃ | |
1639351-92-0 | Mc-Val-Cit-PAB-Cl | | C28H39ClN6O6 | 591.1 | | |
1639352-03-6 | MC-VC-PABC-DNA31 | | C77H96N10O21 | 1497.64 | | |
1639357-93-9 | rel-2-((3aR,6aS)-5-甲基六氢吡咯并[3,4-c]吡咯-2(1H)-基)-N-((5-甲基吡嗪-2-基)甲基)-5-氧代-5H-苯并[4,5]噻唑并[3,2-a][1,8]萘啶-6-甲酰胺 | rel-2-((3aR,6aS)-5-Methylhexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)-N-((5-methylpyrazin-2-yl)methyl)-5-oxo-5H-benzo[4,5]thiazolo[3,2-a][1,8]naphthyridine-6-carboxamide | C28H27N7O2S | 525.62 | | |
163936-30-9 | | ethyl 2,4,5-trimethoxybenzoate | | | | |
1639373-35-5 | | 3,6-dichloro-2,4-dimethylpyridine | C7H7Cl2N | 176.04 | | 231.4±35.0°C at 760 mmHg |